1-6 of 6
Saturnino Haya
Close
Sort by
Journal Articles

National Survey on the Use of Mobile Applications in Patients with Hemophilia and Other Coagulopathies

Juan Eduardo Megias, Santiago Bonanad Boix, Antonio Palomero Massanet, Manuel Rodríguez López, Mariana Canaro, Saturnino Haya, Ana R. Cid, Emilio Monte, Pau Bosch, Guillermo Sanz, José Luis Poveda Andrés
Journal: Blood
Blood (2022) 140 (Supplement 1): 11308–11309.
https://doi.org/10.1182/blood-2022-169938
Published: 2022
Journal Articles

Cross-Sectional Comparative Study of PK-Guided Switch between Standard Half-Life and Extended Half-Life Factor VIII Products

Juan Eduardo Megias, Santiago Bonanad Boix, MD, María Fernanda Martínez García, MD, Rubén Berrueco, MD, Maria Eva Mingot-Castellano, PhD MD, Manuel Rodríguez López, MD, Mariana Canaro, MD, José Mateo Arranz, MD, Itziar Larrodé Leciñena, PharmD, Saturnino Haya, MD, Amparo Santamaria Ortiz, MD, Carmen Albo, MD, Montserrat Mesegué Medea, MD, Antonio Palomero-Massanet, PharmD, Noelia Vilalta Seto, MD, José Manuel Calvo Villas, Ana R Cid, Gustavo Robayo, MD, José Luis Poveda Andrés, Guillermo F. Sanz, MD PhD, Alfonso Iorio
Journal: Blood
Blood (2019) 134 (Supplement_1): 2405.
https://doi.org/10.1182/blood-2019-127946
Published: 2019
Journal Articles

Benefits of Ehl Factor VIII Replacement Therapy in Hemophilia: Observations on Coverage, Physical Activity and Phisiotherapy

Felipe Querol, MD PhD, Sofía Pérez-Alenda, PhD, Juan Eduardo Megias, Juan José Carrasco, MSc, Marta Aguilar, PhD, Saturnino Haya, MD, Ana R Cid, Santiago Bonanad Boix, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2455.
https://doi.org/10.1182/blood-2019-125651
Published: 2019
Journal Articles

Individualized Prophylactic Treatment with Recombinant Factor VIII in Severe or Moderate Haemophilia a Patients. Association Between Pharmacokinetic Parameters and Clinical Variables

Juan Eduardo Megías-Vericat, PharmD, María Remedios Marqués, PhD, Saturnino Haya, MD, Ana Rosa Cid, MD, Felipe Querol, MD, Emilio Monte, PhD, María García-Dasí, Patricia Caunedo, Carmen Vila, Pau Bosch, Rafael Curats, Miguel Ángel Sanz, MD PhD, José Luis Poveda, PhD, Santiago Bonanad, MD
Journal: Blood
Blood (2016) 128 (22): 3802.
https://doi.org/10.1182/blood.V128.22.3802.3802
Published: 2016
Journal Articles

Factor VIII gene ( F8 ) mutation and risk of inhibitor development in nonsevere hemophilia A

Corien L. Eckhardt, Alice S. van Velzen, Marjolein Peters, Jan Astermark, Paul P. Brons, Giancarlo Castaman, Marjon H. Cnossen, Natasja Dors, Carmen Escuriola-Ettingshausen, Karly Hamulyak, Daniel P. Hart, Charles R. M. Hay, Saturnino Haya, Waander L. van Heerde, Cedric Hermans, Margareta Holmström, Victor Jimenez-Yuste, Russell D. Keenan, Robert Klamroth, Britta A. P. Laros-van Gorkom, Frank W. G. Leebeek, Ri Liesner, Anne Mäkipernaa, Christoph Male, Evelien Mauser-Bunschoten, Maria G. Mazzucconi, Simon McRae, Karina Meijer, Michael Mitchell, Massimo Morfini, Marten Nijziel, Johannes Oldenburg, Kathelijne Peerlinck, Pia Petrini, Helena Platokouki, Sylvia E. Reitter-Pfoertner, Elena Santagostino, Piercarla Schinco, Frans J. Smiers, Berthold Siegmund, Annarita Tagliaferri, Thynn T. Yee, Pieter Willem Kamphuisen, Johanna G. van der Bom, Karin Fijnvandraat
Journal: Blood
Blood (2013) 122 (11): 1954–1962.
https://doi.org/10.1182/blood-2013-02-483263
Published: 2013
Includes: Supplemental data
Journal Articles

Preliminary Observations from the European Study on Orthopedic Status (ESOS) in Hemophilia Patients with Inhibitors.

Massimo Morfini, Saturnino Haya, Hartmut Pollmann, Berthold Siegmund, Natalie Stieltjes, Gerry Dolan, Christopher Ludlam
Journal: Blood
Blood (2006) 108 (11): 1037.
https://doi.org/10.1182/blood.V108.11.1037.1037
Published: 2006